Finally, NF-κB activity was assessed in nuclear extracts from sudemycin-treated CLL cells both in SF3B1-mutated and unmutated cases by means of the p65 DNA binding capacity. This evidence concerns the gene NFKB1 and B-cell chronic lymphocytic leukemia.